🇺🇸 FDA
Patent

US 8999349

HMGB1-derived peptides enhance immune response to antigens

granted A61KA61K2039/55505A61K2039/55516

Quick answer

US patent 8999349 (HMGB1-derived peptides enhance immune response to antigens) held by The Regents of the University of California expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/55505, A61K2039/55516, A61K2039/55555, A61K2039/57